eWEEK content and product recommendations are editorially independent. We may make money when you click on links to our partners. Learn More. Oracle has expanded its move into pharmaceutical ...

After years of using its digital health feedback system in clinical trials and studies, Proteus Digital Health, and partner Otsuka Pharmaceuticals, are poised to launch the first mass market drug to ...

Digital medicine company Proteus Digital Health has raised an additional $52 million from undisclosed investors following a whopping $120 million raise the company announced just last month. That ...

Proteus Digital Health—makers of an ingestible sensor embedded within a pill to track medication usage—has filed for bankruptcy, after failing to raise funding in part due to the COVID-19 pandemic.

Agreement will exploit Proteus’ technologies designed to provide feedback on factors such as patient physiology and compliance. Proteus Biomedical will receive $24 million worth of cash and equity ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Proteus Digital Health, Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared its ingestible sensor for marketing as a medical device ...

Proteus (News - Alert) Biomedical recently announced European Union approval of its ingestible sensor and personal physiologic monitor system. The sensors are designed to be safe to swallow in order ...

With Proteus Digital Health's tracker riding in a tablet treating mental health disorders, patients (and their caregivers and doctors) will be able to tell that the medicine has been ingested. A ...

Proteus Digital Health has announced it has received FDA clearance for an ingestible sensor, according to a news release. The ingestible sensor, formally referred to as the Ingestion Event Marker, can ...